Clinical Trial Update: Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fulvestrant and/or trastuzumab as first-line therapy for postmenopausal women with stage IV breast cancer; study terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Translational Oncology Research International | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-02-11